Please provide your email address to receive an email when new articles are posted on . Of the 48 melanoma cases among Black patients, 28 were located on the feet. Of the 13 patients that progressed ...

Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...

Please provide your email address to receive an email when new articles are posted on . Five-year recurrence-free survival was 55.1% with nevus-associated acral melanoma (NAAM) vs. 42.3% with de novo ...

Chinese patients with advanced acral melanoma achieved a small but significant increase in progression-free survival when treated with toripalimab versus dacarbazine. While the overall response rate ...

Investigators evaluated the efficacy and safety of toripalimab versus dacarbazine as the first-line treatment in advanced melanoma predominantly of acral subtype.

WOBURN, Mass., Oct. 19, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced ...

A new study found that Black men had higher rates of advanced melanoma compared to white men. Black men also had lower five-year survival rates for skin cancer. Here are some of the most important ...

Tumor-Treating Fields Open the Door to Progress for Patients With Locally Advanced Pancreatic Cancer We analyzed prospectively collected data from 442 patients with metastatic cutaneous melanoma who ...